Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TGN-S11 |
| Synonyms | |
| Therapy Description |
TGN-S11 is an anti-viral agent with potential antitumor activity (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TGN-S11 | TGN S11|TGNS11 | TGN-S11 is an anti-viral agent with potential antitumor activity (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05826275 | Phase I | TGN-S11 Pembrolizumab + TGN-S11 | Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer | Completed | USA | 0 |